| BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
20 |
serial mean |
25.0 |
mmHg |
3.0 |
13.42 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
|
67303 |
151 |
| SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
9 |
serial mean |
24.0 |
mmHg |
4.0 |
12.0 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
|
67304 |
151 |
| SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93.0 days
| 12 |
serial mean |
427.0 |
beats/min |
6.0 |
20.78 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
65469 |
151 |
| SS/JrHsdMcwi |
plasma total cholesterol level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood cholesterol amount |
female |
92.0 days-94.0 days |
12 |
|
76.0 |
mg/dl |
4.4 |
15.24 |
plasma total cholesterol measurement test |
|
0.0 |
|
|
|
67290 |
151 |
| SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
34.0 |
mmHg |
3.0 |
10.82 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
|
67300 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
111.8 |
mmHg |
3.9 |
17.87 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69527 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
160.2 |
mmHg |
3.5 |
12.62 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69534 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (100 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
147.2 |
mmHg |
3.9 |
14.06 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69532 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
128.6 |
mmHg |
4.0 |
18.33 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69537 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
20 |
serial mean |
135.6 |
mmHg |
3.2 |
14.31 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69539 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
16 |
serial mean |
118.6 |
mmHg |
3.4 |
13.6 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69543 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
138.6 |
mmHg |
3.8 |
17.41 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69547 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
9 |
serial mean |
159.1 |
mmHg |
6.4 |
19.2 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69550 |
151 |
| SS/JrHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine sodium amount |
female |
92.0 days-94.0 days |
14 |
|
0.56 |
mEq/d |
0.06 |
0.21 |
unspecified method |
|
0.0 |
|
urine sodium analysis |
umol/min |
69469 |
151 |
| BN/NHsdMcwi |
urine creatinine level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine creatinine amount |
female |
92.0 days-94.0 days |
25 |
|
56.4 |
mg/dl |
4.95 |
24.75 |
urine creatinine analysis |
|
0.0 |
|
|
|
69475 |
151 |
| BN/NHsdMcwi |
urine creatinine excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine creatinine amount |
female |
92.0 days-94.0 days |
25 |
|
0.0 |
mg/d |
0.0 |
0.0 |
urine creatinine analysis |
|
0.0 |
|
|
mg/min |
69477 |
151 |
| SS/JrHsdMcwi |
urine potassium excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine potassium amount |
female |
92.0 days-94.0 days |
14 |
|
0.92 |
mEq/d |
0.07 |
0.27 |
unspecified method |
|
0.0 |
|
urine potassium analysis |
umol/min |
69474 |
151 |
| BN/NHsdMcwi |
creatinine clearance |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
glomerular filtration trait |
female |
92.0 days-94.0 days |
8 |
|
1.1 |
ml/min |
0.2 |
0.57 |
urine creatinine analysis |
|
0.0 |
|
|
mg/min |
69479 |
151 |
| SS/JrHsdMcwi |
creatinine clearance |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
glomerular filtration trait |
female |
92.0 days-94.0 days |
10 |
|
1.08 |
ml/min |
0.37 |
1.17 |
urine creatinine analysis |
|
0.0 |
|
|
mg/min |
69480 |
151 |
| SS/JrHsdMcwi |
white blood cell count |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
leukocyte quantity |
female |
92.0 days-94.0 days |
9 |
|
0.01 |
x 1000 cells/ul |
1044.0 |
3132.0 |
isolated cell counting method |
|
0.0 |
|
|
|
69496 |
151 |
| BN/NHsdMcwi |
plasma high density lipoprotein cholesterol level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood HDL cholesterol amount |
female |
92.0 days-94.0 days |
9 |
|
44.2 |
mg/dl |
2.2 |
6.6 |
plasma high-density lipoprotein-cholesterol measurement test |
|
0.0 |
|
|
|
69503 |
151 |
| BN/NHsdMcwi |
plasma triglyceride level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood triglyceride amount |
female |
92.0 days-94.0 days |
7 |
|
0.72 |
mmol/l |
0.11 |
0.3 |
plasma triglyceride analysis |
|
0.0 |
|
|
|
67291 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (100 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
132.9 |
mmHg |
3.8 |
17.41 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69531 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (0.5 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
120.4 |
mmHg |
5.3 |
24.29 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69535 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
9 |
serial mean |
160.0 |
mmHg |
6.7 |
20.1 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69548 |
151 |
| SS/JrHsdMcwi |
urine sodium level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine sodium amount |
female |
92.0 days-94.0 days |
14 |
|
149.5 |
mmol/l |
5.2 |
19.46 |
unspecified method |
|
0.0 |
|
urine sodium analysis |
|
69467 |
151 |
| BN/NHsdMcwi |
urine potassium excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine potassium amount |
female |
92.0 days-94.0 days |
22 |
|
0.88 |
mEq/d |
0.06 |
0.27 |
unspecified method |
|
0.0 |
|
urine potassium analysis |
umol/min |
69473 |
151 |
| SS/JrHsdMcwi |
plasma high density lipoprotein cholesterol level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood HDL cholesterol amount |
female |
92.0 days-94.0 days |
12 |
|
68.1 |
mg/dl |
4.5 |
15.59 |
plasma high-density lipoprotein-cholesterol measurement test |
|
0.0 |
|
|
|
69504 |
151 |
| SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
39.0 |
mmHg |
6.0 |
21.63 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
|
67302 |
151 |
| BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) then tactile electric shock exposure (2 %) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92.0 days-94.0 days |
14 |
serial mean |
16.0 |
mmHg |
3.0 |
11.22 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
66149 |
151 |
| BN/NHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92.0 days-94.0 days |
14 |
serial mean |
72.0 |
mmHg |
2.0 |
7.48 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
65464 |
151 |
| SS/JrHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92.0 days-94.0 days |
12 |
serial mean |
126.0 |
mmHg |
5.0 |
17.32 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
65465 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92.0 days-94.0 days |
14 |
serial mean |
89.0 |
mmHg |
2.0 |
7.48 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
65466 |
151 |
| SS/JrHsdMcwi |
plasma renin activity level |
controlled sodium content diet (0.4 %) (for 35 days) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renin activity |
female |
95.0 days
| 7 |
|
4.7 |
ng/ml/h |
1.6 |
4.23 |
ex vivo blood analysis |
|
0 |
|
|
|
65473 |
151 |
| BN/NHsdMcwi |
plasma renin activity level |
controlled sodium content diet (0.4 %) (for 35 days) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renin activity |
female |
95.0 days
| 11 |
|
9.6 |
ng/ml/h |
1.0 |
3.32 |
ex vivo blood analysis |
|
0 |
|
|
|
65474 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
139.1 |
mmHg |
3.6 |
16.5 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69533 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
9 |
serial mean |
132.0 |
mmHg |
7.0 |
21.0 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69542 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
159.0 |
mmHg |
6.4 |
23.08 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69538 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
17 |
serial mean |
144.9 |
mmHg |
3.1 |
12.78 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69549 |
151 |
| BN/NHsdMcwi |
urine sodium level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine sodium amount |
female |
92.0 days-94.0 days |
22 |
|
100.4 |
mmol/l |
6.5 |
30.49 |
unspecified method |
|
0.0 |
|
urine sodium analysis |
|
69466 |
151 |
| BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine sodium amount |
female |
92.0 days-94.0 days |
22 |
|
0.46 |
mEq/d |
0.03 |
0.13 |
unspecified method |
|
0.0 |
|
urine sodium analysis |
umol/min |
69468 |
151 |
| BN/NHsdMcwi |
urine potassium level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine potassium amount |
female |
92.0 days-94.0 days |
22 |
|
93.4 |
mmol/l |
5.7 |
26.74 |
unspecified method |
|
0.0 |
|
urine potassium analysis |
|
69471 |
151 |
| SS/JrHsdMcwi |
plasma creatinine level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood creatinine amount |
female |
92.0 days-94.0 days |
11 |
|
1.05 |
mg/dl |
0.23 |
0.76 |
plasma creatinine analysis |
|
0.0 |
|
urine potassium analysis |
umol/min |
69486 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92.0 days-94.0 days |
12 |
serial mean |
142.0 |
mmHg |
5.0 |
17.32 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
65467 |
151 |
| BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93.0 days
| 14 |
serial mean |
395.0 |
beats/min |
7.0 |
26.19 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
65468 |
151 |
| SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) then tactile electric shock exposure (2 %) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92.0 days-94.0 days |
8 |
serial mean |
11.0 |
mmHg |
3.0 |
8.49 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
66150 |
151 |
| BN/NHsdMcwi |
plasma total cholesterol level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood cholesterol amount |
female |
92.0 days-94.0 days |
10 |
|
56.0 |
mg/dl |
2.1 |
6.64 |
plasma total cholesterol measurement test |
|
0.0 |
|
|
|
67289 |
151 |
| BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
19 |
serial mean |
22.0 |
mmHg |
3.0 |
13.08 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
|
67301 |
151 |
| BN/NHsdMcwi |
timed urine volume |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine output |
female |
92.0 days-94.0 days |
25 |
|
9.86 |
ml/d |
0.4 |
2.0 |
urine volume measurement method |
|
0.0 |
|
|
needs ml/d default |
69464 |
151 |
| SS/JrHsdMcwi |
timed urine volume |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine output |
female |
92.0 days-94.0 days |
15 |
|
7.8 |
ml/d |
0.6 |
2.32 |
urine volume measurement method |
|
0.0 |
|
|
needs ml/d default |
69465 |
151 |
| BN/NHsdMcwi |
plasma creatinine level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood creatinine amount |
female |
92.0 days-94.0 days |
8 |
|
0.42 |
mg/dl |
0.11 |
0.31 |
plasma creatinine analysis |
|
0.0 |
|
urine potassium analysis |
umol/min |
69485 |
151 |
| BN/NHsdMcwi |
white blood cell count |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
leukocyte quantity |
female |
92.0 days-94.0 days |
13 |
|
0.02 |
x 1000 cells/ul |
1306.0 |
4708.85 |
isolated cell counting method |
|
0.0 |
|
|
|
69495 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (20 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
131.3 |
mmHg |
4.2 |
15.14 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69530 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
168.4 |
mmHg |
7.0 |
25.24 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69540 |
151 |
| BN/NHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92.0 days-94.0 days |
14 |
serial mean |
110.0 |
mmHg |
3.0 |
11.22 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
65462 |
151 |
| SS/JrHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92.0 days-94.0 days |
12 |
serial mean |
160.0 |
mmHg |
6.0 |
20.78 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
65463 |
151 |
| SS/JrHsdMcwi |
plasma triglyceride level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood triglyceride amount |
female |
92.0 days-94.0 days |
11 |
|
1.4 |
mmol/l |
0.21 |
0.71 |
plasma triglyceride analysis |
|
0.0 |
|
|
|
67292 |
151 |
| BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
20 |
serial mean |
27.0 |
mmHg |
2.0 |
8.94 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
|
67299 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
126.0 |
mmHg |
4.1 |
14.78 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69528 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (20 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
20 |
serial mean |
118.9 |
mmHg |
4.4 |
19.68 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69529 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (0.5 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
141.7 |
mmHg |
7.4 |
26.68 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69536 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
111.3 |
mmHg |
4.6 |
21.08 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69541 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
9 |
serial mean |
134.7 |
mmHg |
7.4 |
22.2 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69544 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
137.4 |
mmHg |
4.0 |
18.33 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69545 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
9 |
serial mean |
159.0 |
mmHg |
7.1 |
21.3 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69546 |
151 |
| SS/JrHsdMcwi |
urine potassium level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine potassium amount |
female |
92.0 days-94.0 days |
14 |
|
124.4 |
mmol/l |
8.8 |
32.93 |
unspecified method |
|
0.0 |
|
urine potassium analysis |
|
69472 |
151 |
| SS/JrHsdMcwi |
urine creatinine level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine creatinine amount |
female |
92.0 days-94.0 days |
17 |
|
111.7 |
mg/dl |
10.5 |
43.29 |
urine creatinine analysis |
|
0.0 |
|
|
|
69476 |
151 |
| SS/JrHsdMcwi |
urine creatinine excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine creatinine amount |
female |
92.0 days-94.0 days |
16 |
|
0.0 |
mg/d |
0.0 |
0.0 |
urine creatinine analysis |
|
0.0 |
|
|
mg/min |
69478 |
151 |